[HTML][HTML] Pleotropic effects of polyphenols in cardiovascular system

T Behl, S Bungau, K Kumar, G Zengin, F Khan… - Biomedicine & …, 2020 - Elsevier
Numerous epidemiological and clinical studies demonstrate the beneficial effects of
naturally occurring, polyphenol supplementations, on cardiovascular system. The present …

Coordinated modulation of energy metabolism and inflammation by branched-chain amino acids and fatty acids

Z Ye, S Wang, C Zhang, Y Zhao - Frontiers in endocrinology, 2020 - frontiersin.org
As important metabolic substrates, branched-chain amino acids (BCAAs) and fatty acids
(FAs) participate in many significant physiological processes, such as mitochondrial …

[HTML][HTML] Dyslipidemia involvement in the development of polycystic ovary syndrome

Q Liu, Y Xie, L Qu, M Zhang, Z Mo - Taiwanese journal of obstetrics and …, 2019 - Elsevier
Polycystic ovary syndrome (PCOS) is widely accepted as the most common endocrine
abnormality in women of childbearing age and may be accompanied by dyslipidemia …

Non-alcoholic fatty liver disease in patients with polycystic ovary syndrome: a systematic review, meta-analysis, and meta-regression

R Manzano-Nunez, M Santana-Dominguez… - Journal of Clinical …, 2023 - mdpi.com
Background: The metabolic effects of polycystic ovary syndrome (PCOS) may increase the
risk of non-alcoholic fatty liver disease (NAFLD). However, the burden of NAFLD in PCOS …

Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome

IG Lempesis, SJ Apple, G Duarte… - Diabetes/Metabolism …, 2023 - Wiley Online Library
Polycystic ovary syndrome (PCOS) is a complex endocrinopathy affecting many women of
reproductive age. Although its physiology is poorly understood, hyperandrogenemia and …

Adipose tissue insulin resistance is longitudinally associated with adipose tissue dysfunction, circulating lipids, and dysglycemia: the PROMISE cohort

Z Semnani-Azad, PW Connelly, RP Bazinet… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE To determine the association of adipose tissue insulin resistance with
longitudinal changes in biomarkers of adipose tissue function, circulating lipids, and …

Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus …

A Podfigurna, B Meczekalski, F Petraglia… - Journal of …, 2020 - Springer
Introduction Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting 5–
10% of women of reproductive age. It is characterized by chronic anovulation leading to …

Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple‐blind …

M Jabarpour, A Aleyasin… - Phytotherapy …, 2024 - Wiley Online Library
Astaxanthin (ASX) is a natural carotenoid compound found in several of microorganisms
and seafood. It may have numerous therapeutic benefits for polycystic ovarian syndrome …

TMT based proteomic analysis of human follicular fluid from overweight/obese and normal-weight patients with polycystic ovary syndrome

X Zhang, X Xu, P Li, F Zhou, L Kong, J Qiu… - Frontiers in …, 2019 - frontiersin.org
Background: Polycystic ovary syndrome (PCOS) is a major endocrine and metabolic
disorder with heterogeneous manifestations and complex etiology. As a leading cause of …

Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome

P Falcetta, E Benelli, A Molinaro, C Di Cosmo… - Journal of …, 2021 - Springer
Purpose To assess the distribution of clinical features and metabolic abnormalities of
polycystic ovary syndrome (PCOS) women according to their age. Methods Retrospective …